283 related articles for article (PubMed ID: 11589833)
1. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.
Biswas S; Reddy GS; Srinivasan VA; Rangarajan PN
Hum Gene Ther; 2001 Oct; 12(15):1917-22. PubMed ID: 11589833
[TBL] [Abstract][Full Text] [Related]
2. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
Kaur M; Saxena A; Rai A; Bhatnagar R
FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
[TBL] [Abstract][Full Text] [Related]
4. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
6. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
[TBL] [Abstract][Full Text] [Related]
7. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
Huang F; Ahmad W; Duan M; Liu Z; Guan Z; Zhang M; Qiao B; Li Y; Song Y; Song Y; Chen Y; Amjad Ali M
Acta Virol; 2015 Jun; 59(2):117-24. PubMed ID: 26104328
[TBL] [Abstract][Full Text] [Related]
9. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
[TBL] [Abstract][Full Text] [Related]
11. A recombinant human adenovirus vaccine against rabies.
Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
[TBL] [Abstract][Full Text] [Related]
12. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice.
Wunderli PS; Dreesen DW; Miller TJ; Baer GM
Am J Vet Res; 2003 Apr; 64(4):499-505. PubMed ID: 12693543
[TBL] [Abstract][Full Text] [Related]
13. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
[TBL] [Abstract][Full Text] [Related]
14. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
[TBL] [Abstract][Full Text] [Related]
15. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
Ray NB; Ewalt LC; Lodmell DL
Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
[TBL] [Abstract][Full Text] [Related]
16. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
[TBL] [Abstract][Full Text] [Related]
17. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
Vrzal V; Cupera Z; Chumela J; Zatloukal L
Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
[TBL] [Abstract][Full Text] [Related]
18. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
Wu X; Franka R; Henderson H; Rupprecht CE
Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
